The Promise and Peril of Fast Tracking Coronavirus Vaccine Development | WSJ

How to Make Sense of Coronavirus Data | WSJПодробнее

How Scientists Are Trying to Develop a Coronavirus Vaccine | WSJПодробнее

The Logistics Behind the U.S. Covid Vaccine Rollout | WSJПодробнее

The Critical Coronavirus-Busting Therapies, Explained | WSJПодробнее

The Promise and Peril of Fast-Tracking the Coronavirus Vaccine | WSJПодробнее

Three Tech Tips for Booking a Covid-19 Vaccine Appointment | WSJПодробнее

How Omicron Challenges U.S. and China on Vaccine Diplomacy | WSJПодробнее

What China and Russia Hope to Gain From Sharing Their Covid Vaccines | WSJПодробнее

Breakthrough Covid-19 Cases Raise Questions About Immunity | WSJПодробнее

Are Covid-19 Vaccine Incentives Paying Off? | WSJПодробнее

What It Would Take to Reach Herd Immunity | WSJПодробнее

The Debate Over Whether Colleges Can Require Covid-19 Vaccines | WSJПодробнее

How Covid’s Delta Variant Quickly Spread Globally | WSJПодробнее

Inside Brazil’s Fight Against P.1, a Fast-Spreading Covid-19 Variant | WSJПодробнее

Covid-19 Boosters Are Coming: Here’s What to Know | WSJПодробнее

Should We Get a Second Booster Vaccine? What the Science Says | WSJПодробнее

'Not such a good idea' to fast-track a coronavirus vaccine, says infectious diseases expertПодробнее

How Coronavirus Became a Global Pandemic | WSJПодробнее

What Covid Lockdowns and Disruptions in Europe Signal to the U.S. | WSJПодробнее

Vaccine Efficacy Numbers, Explained | WSJПодробнее